FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2091978623> ?p ?o ?g. }

• W2091978623 endingPage "117" @default.
• W2091978623 startingPage "111" @default.
• W2091978623 abstract "Objectives. We sought to estimate the risk of death and recurrent myocardial infarction associated with the use of calcium antagonists after myocardial infarction in a population-based cohort study. Background. Calcium antagonists are commonly prescribed after myocardial infarction, but their long-term effects are not well established. Methods. Patients 25 to 69 years old with a suspected myocardial infarction were identified and followed up through a community-based register of myocardial infarction and cardiac death (part of the World Health Organization Monitoring Trends and Determinants in Cardiovascular Disease [MONICA] Project in Newcastle, Australia). Data were collected by review of medical records, in-hospital interview and review of death certificates. Results. From 1989 to 1993, 3,982 patients with a nonfatal suspected myocardial infarction were enrolled in the study. At hospital discharge, 1,001 patients were treated with beta-adrenergic blocking agents, 923 with calcium antagonists, 711 with both beta-blockers and calcium antagonists and 1,346 with neither drug. Compared with patients given beta-blockers, patients given calcium antagonists were more likely to suffer myocardial infarction or cardiac death (adjusted relative risk [RR] 1.4, 95% confidence interval [CI] 1.0 to 1.9), cardiac death (RR 1.6, 95% CI 1.0 to 2.7) and death from all causes (RR 1.7, 95% CI 1.1 to 2.6). Compared with patients given neither beta-blockers nor calcium antagonists, patients given calcium antagonists were not at increased risk of myocardial infarction or cardiac death (RR 1.0, 95% CI 0.8 to 1.3), cardiac death (RR 0.9, 95% CI 0.6 to 1.2) or death from all causes (RR 1.0, 95% CI 0.7 to 1.3). No excess in risk of myocardial infarction or cardiac death was observed among patients taking verapamil (RR 0.9, 95% CI 0.6 to 1.6), diltiazem (RR 1.1, 95% CI 0.8 to 1.4) or nifedipine (RR 1.3, 95% CI 0.7 to 2.2) compared with patients taking neither calcium antagonists nor beta-blockers. Conclusions. These results are consistent with randomized trial data showing benefit from beta-blockers after myocardial infarction and no effect on the risk of recurrent myocardial infarction and death with the use of calcium antagonists. Comparisons between beta-blockers and calcium antagonists favor beta-blockers because of the beneficial effects of beta-blockers and not because of adverse effects of calcium antagonists." @default.
• W2091978623 created "2016-06-24" @default.
• W2091978623 creator A5013471410 @default.
• W2091978623 creator A5057362562 @default.
• W2091978623 creator A5061394311 @default.
• W2091978623 creator A5083659255 @default.
• W2091978623 date "1998-01-01" @default.
• W2091978623 modified "2023-09-26" @default.
• W2091978623 title "Outcome With Calcium Channel Antagonists After Myocardial Infarction: A Community-Based Study" @default.
• W2091978623 cites W1966953116 @default.
• W2091978623 cites W1971027475 @default.
• W2091978623 cites W1979082324 @default.
• W2091978623 cites W1980012325 @default.
• W2091978623 cites W1983107066 @default.
• W2091978623 cites W1983321059 @default.
• W2091978623 cites W2003772660 @default.
• W2091978623 cites W2004566712 @default.
• W2091978623 cites W2008789150 @default.
• W2091978623 cites W2009990022 @default.
• W2091978623 cites W2023282304 @default.
• W2091978623 cites W2029390260 @default.
• W2091978623 cites W2030257202 @default.
• W2091978623 cites W2031232834 @default.
• W2091978623 cites W2031498851 @default.
• W2091978623 cites W2038602302 @default.
• W2091978623 cites W2045209579 @default.
• W2091978623 cites W2045948977 @default.
• W2091978623 cites W2054054398 @default.
• W2091978623 cites W2062309991 @default.
• W2091978623 cites W2064355680 @default.
• W2091978623 cites W2074393245 @default.
• W2091978623 cites W2083625183 @default.
• W2091978623 cites W2083772300 @default.
• W2091978623 cites W2090738166 @default.
• W2091978623 cites W2092805838 @default.
• W2091978623 cites W2106073810 @default.
• W2091978623 cites W2170807373 @default.
• W2091978623 cites W2318480619 @default.
• W2091978623 cites W2322661993 @default.
• W2091978623 cites W2325875262 @default.
• W2091978623 cites W2326997818 @default.
• W2091978623 cites W2727581825 @default.
• W2091978623 cites W4231250029 @default.
• W2091978623 cites W4246140365 @default.
• W2091978623 cites W4292229884 @default.
• W2091978623 cites W4301350705 @default.
• W2091978623 doi "https://doi.org/10.1016/s0735-1097(97)00445-2" @default.
• W2091978623 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9426027" @default.
• W2091978623 hasPublicationYear "1998" @default.
• W2091978623 type Work @default.
• W2091978623 sameAs 2091978623 @default.
• W2091978623 citedByCount "21" @default.
• W2091978623 countsByYear W20919786232015 @default.
• W2091978623 countsByYear W20919786232018 @default.
• W2091978623 crossrefType "journal-article" @default.
• W2091978623 hasAuthorship W2091978623A5013471410 @default.
• W2091978623 hasAuthorship W2091978623A5057362562 @default.
• W2091978623 hasAuthorship W2091978623A5061394311 @default.
• W2091978623 hasAuthorship W2091978623A5083659255 @default.
• W2091978623 hasBestOaLocation W20919786231 @default.
• W2091978623 hasConcept C126322002 @default.
• W2091978623 hasConcept C164705383 @default.
• W2091978623 hasConcept C2777798775 @default.
• W2091978623 hasConcept C2908647359 @default.
• W2091978623 hasConcept C44249647 @default.
• W2091978623 hasConcept C500558357 @default.
• W2091978623 hasConcept C71924100 @default.
• W2091978623 hasConcept C82789193 @default.
• W2091978623 hasConcept C99454951 @default.
• W2091978623 hasConceptScore W2091978623C126322002 @default.
• W2091978623 hasConceptScore W2091978623C164705383 @default.
• W2091978623 hasConceptScore W2091978623C2777798775 @default.
• W2091978623 hasConceptScore W2091978623C2908647359 @default.
• W2091978623 hasConceptScore W2091978623C44249647 @default.
• W2091978623 hasConceptScore W2091978623C500558357 @default.
• W2091978623 hasConceptScore W2091978623C71924100 @default.
• W2091978623 hasConceptScore W2091978623C82789193 @default.
• W2091978623 hasConceptScore W2091978623C99454951 @default.
• W2091978623 hasIssue "1" @default.
• W2091978623 hasLocation W20919786231 @default.
• W2091978623 hasLocation W20919786232 @default.
• W2091978623 hasOpenAccess W2091978623 @default.
• W2091978623 hasPrimaryLocation W20919786231 @default.
• W2091978623 hasRelatedWork W1497823195 @default.
• W2091978623 hasRelatedWork W1966890586 @default.
• W2091978623 hasRelatedWork W2015763030 @default.
• W2091978623 hasRelatedWork W2026996320 @default.
• W2091978623 hasRelatedWork W2049397185 @default.
• W2091978623 hasRelatedWork W2093502227 @default.
• W2091978623 hasRelatedWork W2103442826 @default.
• W2091978623 hasRelatedWork W2371846023 @default.
• W2091978623 hasRelatedWork W2399063111 @default.
• W2091978623 hasRelatedWork W2130232188 @default.
• W2091978623 hasVolume "31" @default.
• W2091978623 isParatext "false" @default.
• W2091978623 isRetracted "false" @default.
• W2091978623 magId "2091978623" @default.
• W2091978623 workType "article" @default.